Belgian neuromuscular and neurodegenerative disorder specialist Augustine Therapeutics has made several executive appointments, including a new chief medical of 12 September 2023
Swedish biotech Oncopeptides has revealed details regarding a formal request from the US Food and Drug Administration to voluntarily withdraw the approval of Pe 25 August 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.